Test foam used to stop dangerous internal abdominal bleeding
Part of Injuries & trauma clinical trials.
This trial tests whether an expandable foam can quickly help slow or control life-threatening bleeding inside the belly. It is designed for emergency situations where surgery to stop the bleeding will happen soon.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re at least 15 years old (or estimated weight over 50 kg if age is unknown)
- You’re in an emergency with severe bleeding shock from a belly (abdominal) source
- Doctors confirm the bleeding is in the abdomen (by seeing it, an ultrasound test, or a procedure that samples fluid from the belly)
- There is no other ongoing, uncontrolled bleeding source besides the abdomen
- You must be on a breathing machine and sedated, and doctors decide within 30 minutes of arriving at the ER
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding the drug tranexamic acid (TXA) to a massive blood transfusion helps control life-threatening bleeding in children who are severely injured. It compares two groups: one gets TXA and the other gets a placebo (a dummy drug with no active ingredient).
This trial compares giving whole blood versus standard care in adults with severe trauma and dangerous blood loss (hemorrhagic shock). The goal is to see if whole blood helps stabilize patients faster and improves outcomes after major bleeding.
This trial tests a treatment called INTERCEPT Fibrinogen Complex (IFC) to help control bleeding in trauma patients. It is given to patients who arrive at the hospital quickly after injury and have low fibrinogen levels.
This trial tests how bleeding from broken leg, arm, or pelvic bones affects patients and looks for better ways to manage shock. It is designed for adults arriving at the hospital within 24 hours of their injury.
This Phase 3 study tests whether giving fibrinogen early can improve outcomes for adults with serious trauma who are actively bleeding. The goal is to help blood clotting work better sooner and potentially reduce complications from uncontrolled bleeding.
This trial compares different blood transfusion approaches for people in hemorrhagic shock from trauma or severe bleeding in the upper digestive tract. It aims to find the safest and most effective way to give blood in emergency situations.
Hear when a new Hemorrhagic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.